Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara C Wimmer

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Patient Safety|May 26, 2022
Eight-Year Trends in Direct-Acting Oral Anticoagulant Dosing, Based on Age and Kidney Function, in Patients With Atrial FibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
The Annals of Pharmacotherapy|May 29, 2014
Medication Regimen Complexity and Unplanned Hospital Readmissions in Older PeopleBarbara C Wimmer, Elsa Dent, J Simon Bell, et al.
Expert Review of Clinical Pharmacology|July 18, 2022
Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapyWoldesellassie M Bezabhe, Jan Radford, Barbara C Wimmer, et al.
Patient Education and Counseling|August 28, 2019
Health information overload among health consumers: A scoping reviewIsraa Khaleel, Barbara C Wimmer, Gregory M Peterson, et al.
Expert Review of Clinical Pharmacology|April 22, 2022
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulantsWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Frontiers in Pharmacology|April 19, 2021
Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial FibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Clinical Medicine Insights. Cardiology|November 9, 2019
Applying the Capability, Opportunity, and Motivation Behaviour Model (COM-B) to Guide the Development of Interventions to Improve Early Detection of Atrial FibrillationAbubakar Ibrahim Jatau, Gregory M Peterson, Luke Bereznicki, et al.
European Journal of Clinical Investigation|November 22, 2020
Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Frontiers in Pharmacology|December 25, 2023
Clinical and economic impact of partnered pharmacist medication charting in the emergency departmentTesfay Mehari Atey, Gregory M Peterson, Mohammed S Salahudeen, et al.
Pharmacy (Basel, Switzerland)|April 26, 2024
Redesigning Medication Management in the Emergency Department: The Impact of Partnered Pharmacist Medication Charting on the Time to Administer Pre-Admission Time-Critical Medicines, Medication Order Completeness, and Venous Thromboembolism Risk AssessmentTesfay Mehari Atey, Gregory M Peterson, Mohammed S Salahudeen, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Patient Safety|May 26, 2022
Eight-Year Trends in Direct-Acting Oral Anticoagulant Dosing, Based on Age and Kidney Function, in Patients With Atrial FibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
The Annals of Pharmacotherapy|May 29, 2014
Medication Regimen Complexity and Unplanned Hospital Readmissions in Older PeopleBarbara C Wimmer, Elsa Dent, J Simon Bell, et al.
Expert Review of Clinical Pharmacology|July 18, 2022
Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapyWoldesellassie M Bezabhe, Jan Radford, Barbara C Wimmer, et al.
Patient Education and Counseling|August 28, 2019
Health information overload among health consumers: A scoping reviewIsraa Khaleel, Barbara C Wimmer, Gregory M Peterson, et al.
Expert Review of Clinical Pharmacology|April 22, 2022
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulantsWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Frontiers in Pharmacology|April 19, 2021
Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial FibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Clinical Medicine Insights. Cardiology|November 9, 2019
Applying the Capability, Opportunity, and Motivation Behaviour Model (COM-B) to Guide the Development of Interventions to Improve Early Detection of Atrial FibrillationAbubakar Ibrahim Jatau, Gregory M Peterson, Luke Bereznicki, et al.
European Journal of Clinical Investigation|November 22, 2020
Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillationWoldesellassie M Bezabhe, Luke R Bereznicki, Jan Radford, et al.
Frontiers in Pharmacology|December 25, 2023
Clinical and economic impact of partnered pharmacist medication charting in the emergency departmentTesfay Mehari Atey, Gregory M Peterson, Mohammed S Salahudeen, et al.
Pharmacy (Basel, Switzerland)|April 26, 2024
Redesigning Medication Management in the Emergency Department: The Impact of Partnered Pharmacist Medication Charting on the Time to Administer Pre-Admission Time-Critical Medicines, Medication Order Completeness, and Venous Thromboembolism Risk AssessmentTesfay Mehari Atey, Gregory M Peterson, Mohammed S Salahudeen, et al.
Pageof 5